ARCHIVES

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

This article is from The Cancer Letter archive.

Vol. 25 No. 33 | September 3, 1999

Download PDF Visit The Full Archive

Related Articles

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

January 11, 2008

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

Clinical Trials Approved By NCI

January 30, 2004

Cancer Epidemiology Hampered By Bureaucratic Delays, Lack of Cooperation, NCI Group Says

September 29, 1978

Congress Passes FDA User Fee Bill, Averting Layoffs.

September 21, 2007

NCI to Fund Research Collaboration At HMOs, Health Care Provider Networks

July 11, 1997